Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence.

Front Immunol · 2025 · PMC12358366 · PMID 40831562

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the difference in NLR before and after DC therapy did not reach statistical significance in both groups of patients due to the small number of patients, NLR seemed to increase in patients with survival <24 months at one month after DC therapy.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.